Fate Therapeutics Inc. buy Wedbush
Start price
27.10.25
/
50%
€1.35
Target price
27.10.26
€6.02
Performance (%)
78.29%
Price
11:16
€2.40
Summary
This prediction is currently active. With a performance of 78.29% the BUY prediction by Wedbush is a big success. This prediction currently runs until 27.10.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Fate Therapeutics Inc. | 14.057% | 14.057% |
| iShares Core DAX® | 2.573% | 5.333% |
| iShares Nasdaq 100 | 4.858% | 0.449% |
| iShares Nikkei 225® | 5.590% | -0.586% |
| iShares S&P 500 | 3.250% | 2.500% |
Comments by Wedbush for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics (NASDAQ:FATE) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $7.00 price target on the stock, up previously from $5.00.
Ratings data for FATE provided by MarketBeat